Patents Assigned to Numedicus Limited
  • Treatment of respiratory depression
    Patent number: 9610291
    Abstract: Tricyclic dibenzothiazepine compounds for use in the treatment of respiratory depression.
    Type: Grant
    Filed: May 10, 2013
    Date of Patent: April 4, 2017
    Assignee: Numedicus Limited
    Inventor: David Cavalla
  • Dibenzothiazepine derivatives and their use in the treatment of CNS disorders
    Patent number: 9487492
    Abstract: A compound of formula I: or a pharmaceutically or veterinarily acceptable salt thereof, or a pharmaceutically or veterinarily acceptable solvate of either entity, wherein: R1, R2, R3, R4, R5, R6, X and m are as defined herein.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: November 8, 2016
    Assignee: NUMEDICUS LIMITED
    Inventor: David Cavalla
  • DIBENZOTHIAZEPINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS
    Publication number: 20140243317
    Abstract: A compound of formula I: or a pharmaceutically or veterinarily acceptable salt thereof, or a pharmaceutically or veterinarily acceptable solvate of either entity, wherein: R1, R2, R3, R4, R5, R6, X and m are as defined herein.
    Type: Application
    Filed: April 16, 2012
    Publication date: August 28, 2014
    Applicant: Numedicus Limited
    Inventor: David Cavalla